Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2044Source: DataRank Database

Pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping is a research paper published in Clinical Pharmacology & Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 37 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access37 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (24 grants)OA: hybridTopics (80)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (39)

Lubbe Wiesner ORCID,Jennifer Norman ORCID,Carole L. Wallis ORCID,Carolyne Onyango‐Makumbi,Tsungai Chipato

Live enrichment

PubMed:32909316

National Institutes of Health

Grant: 3UM1AI106701-12S1

AIDS Clinical Trial Group Laboratory Center

National Institutes of Health

Grant: 5UM1AI106716-07

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center

National Institutes of Health

Grant: 5UM1AI068616-14

SDMC - IMPAACT Leadership Group

National Institutes of Health

Grant: 5UM1AI068634-09

Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)

National Institutes of Health

Grant: 5UM1AI069465-06

Johns Hopkins AIDS Clinical Trials Unit

National Institutes of Health

Grant: 3UM1AI068636-19SC

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

National Institutes of Health

Grant: 7UM1AI068632-07

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group

NIAID NIH HHS

Grant: R01 AI077505

NIAID NIH HHS

Grant: UM1 AI068632

NIMH NIH HHS

Grant: R21 MH083308

NIAID NIH HHS

Grant: UM1 AI068634

NIAID NIH HHS

Grant: UM1 AI069530

NIAID NIH HHS

Grant: UM1 AI069399

NIAID NIH HHS

Grant: UM1 AI068616

NIAID NIH HHS

Grant: UM1 AI106701

NIAID NIH HHS

Grant: UM1 AI069436

NIAID NIH HHS

Grant: U01 AI068632

NICHD NIH HHS

Grant: HHSN275201800001C

NIAID NIH HHS

Grant: UM1 AI069521

NIAID NIH HHS

Grant: UM1 AI069465

NIAID NIH HHS

Grant: UM1 AI106716

NIAID NIH HHS

Grant: U01 AI069436

NICHD NIH HHS

Grant: HHSN275201800001I

NIAID NIH HHS

Grant: UM1 AI068636

hybridLicense: cc-by-nc

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2044

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2044

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cpt.2044

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2044

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8048881

Fields of Study

03 medical and health sciences0302 clinical medicineAdolescentAdultAlkynesAnti-HIV AgentsAntitubercular AgentsArylamine N-AcetyltransferaseBenzoxazinesBody WeightCyclopropanesCytochrome P-450 CYP2B6Double-Blind MethodDrug InteractionsEquivalence Trials as TopicFemaleGenotypeHIV InfectionsHumansIsoniazidMetabolic Clearance RateMiddle AgedPregnancyProspective StudiesReverse Transcriptase InhibitorsTuberculosisYoung Adult

MeSH Terms

AdolescentAdultAlkynesAnti-HIV AgentsAntitubercular AgentsArylamine N-AcetyltransferaseBenzoxazinesBody WeightCyclopropanesCytochrome P-450 CYP2B6Double-Blind MethodDrug InteractionsEquivalence Trials as TopicFemaleGenotypeHIV InfectionsHumansIsoniazidMetabolic Clearance RateMiddle AgedPregnancyProspective StudiesReverse Transcriptase InhibitorsTuberculosisYoung Adult

Keywords

AdultCyclopropanesAdolescentGenotypeAnti-HIV AgentsArylamine N-AcetyltransferaseMetabolic Clearance RateAntitubercular Agents610HIV InfectionsEquivalence Trials as TopicPregnantDouble-Blind MethodIsoniazidHumansPharmacokineticsDrug InteractionsResearchBody WeightHIVMiddle Aged620BenzoxazinesCytochrome P-450 CYP2B6TBAlkynesFemaleEfavirenz

Sustainable Development Goals

SDG 3: 3. Good health